Return of Takeda’s Parathyroid Hormone Injection Delayed Indefinitely

Takeda faces yet another setback by the U.S. Food and Drug Administration for its parathyroid hormone, natpara. Natpara is intended to help patients navigate low blood calcium due to hypoparathyroidism.